| abstract |
Various embodiments of the present invention provide for modules, devices, systems and methods for measuring or detecting analytes, such as cysteine and/or methionine metabolite levels, in a sample. Various embodiments of the present invention provide for modules, devices, systems and methods for prognosing or diagnosing cancer, for example, prostate, colon, ovarian or breast cancer. Various embodiments of the present invention provide for modules, devices, systems and methods for predicting the risk or probability of cancer recurrence. Various embodiments of the present invention provide for modules, devices, systems and methods for predicting, detecting and/or monitoring cystinuria or cystine stone disease. |